Environmental chemical-induced macrophage dysfunction. by Loose, L D et al.
Environmental Health Perspectives
Vol. 39, pp. 79-91, 1981
Environmental Chemical-Induced
Macrophage Dysfunction
by L. D. Loose,*t J. B. Silkworth,* T. Charbonneau,**
and F. Blumenstock*
Immunomodulation by environmental chemical contaminants and the role immune parameters
play in toxicity and risk assessment studies is of increasing concern. Although considerable
evidence has indicated that various xenobiotics may be immunosuppressive, little attention has
been directed toward ascertaining a specific cellular locus which could be responsible for the
impaired immune responsiveness. Since previous studies had suggested a macrophage defect in
xenobiotic-induced immunosuppression and since macrophages are integral components of an
immune response, an in-depth evaluation of macrophage function was conducted in xenobiotic-
exposed mice. Macrophages isolated from mice receiving PCB, HCB, and dieldrin had no
alteration in their in vitro 02 consumption while at rest or during phagocytosis. In addition, no
alteration in in vitro phagocytic activity, phagocytic capacity or microbicidal activity was
demonstrated. However, a significant impairment in the in vivo phagocytic clearance of a
labelled antigen and an altered tissue distribution of the antigen was observed and was,
perhaps, related, in part, to a significant decrease in serum fibronectin, an opsonic a2
surface-binding glycoprotein. Furthermore, animals exposed to HCB and dieldrin, but not to
PCB, had a profound decrease in their resistance to a challenge tumor cell implant which was
related to a select alteration in tumor cell killing. The adherent spleen cells from HCB-treated
mice had a profound suppression in their tumoricidal activity which was in contrast to
dieldrin-treated mice, where the target cell type appeared to be the nonadherent cells. However,
although dieldrin-exposed adherent cells (macrophages ?) did not appear to have an altered
tumoricidal capacity, all four macrophage types isolated from dieldrin-treated mice had a
significantly impaired ability to process a cellular antigen. Splenic and alveolar macrophages
appeared to be the most sensitive cell types to dieldrin. The present studies suggest that
macrophage dysfunction may be an integral part of xenobiotic-induced immunosuppression
and that the effector but not affector component of macrophage function may be the site of
alteration.
Introduction
Inadvertent modification ofthe immune response
by environmental chemicals and food additives has
been ofincreasing concern. Numerous studies which
have utilized organohalides (1-3), organophosphates
(4), carbamates (5), heavy metals (6-8), and food
additives (9) have demonstrated that these chemi-
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cals have the potential to be immunosuppressive.
One extrapolation of the immunosuppression in-
duced experimentally by these compounds is an
increased susceptibility to a challenge with infec-
tious pathogens and tumor cell implants. Indeed,
following exposure to various xenobiotics, an en-
hanced sensitivity to bacteria (10), viruses (11),
protozoan parasites (12), gram-negative endotoxin
(13), and tumor cell challenges (14) has been
demonstrated.
Potential tissue destruction by the environmen-
tal chemicals resulting in either the release of
"hidden" self-antigens or the formation of altered
tissue macromolecules has raised the question of
79the possible induction of auto-immune diseases. In
this regard, dieldrin (15) and vinyl chloride (16)
exposure have been reported to elicit autoimmune
effects. Without the consideration that the toxicity
and pathologic sequelae observed following chemi-
cal exposure may possibly be autoimmune phenom-
ena, the toxic effects seen after chemical exposure
would be incorrectly attributed to the direct action
of the compound and/or its metabolites.
An additional consideration of the role of the
immune system in toxic manifestations ofchemicals
ofenvironmentalimportanceisthepossibleinfluence
of immunocompetent cells on xenobiotic metabo-
lism. Since most environmental chemicals fulfill the
Landsteiner criteria ofhaptens, a host response to
these compounds would alter both their vascular
clearance and tissue distribution and hence their
catabolism. In support ofthis hypothesis have been
the studies ofAuthrup et al. (17) and Wasserman et
al. (18) which have demonstrated that immuno-
competent cells and/or the immune response per se
can alter the in vitro metabolism ofxenobiotics and
their in vivo pharmacokinetics.
The altered host defense status in environmental
chemical treated animals may be suggested to be
due to a compromised macrophage function since an
essential role of fixed tissue macrophages in both
host resistance to infectious agents and in immune
responsivenesshasbeenamplydemonstrated. Biozzi
et al. (19) reported that an enhanced phagocytic
function of the reticuloendothelial (RE) cells is the
primary mechanism of host defense against gram-
negative and gram-positive bacteria. In reviewing
the literature concerning virus-macrophage inter-
actions, Mims (20) reported that macrophages phago-
cytize virus particles and either support their
growth, allow their survival until they are passed
to other cells, or destroy them. The principal
functionsofmacrophagesinrelationtohemoflagellates
and hemosporidea were initially recognized by
Linton (21) and Taliaferro (22), who observed that
certain parasitoses were primarily infections ofthe
RE cells and that in malaria the chief defense was
phagocytosis by RE cells (23).
In addition to the integral function of macro-
phages in defense against certain bacteria, viruses
and protozoa, they are also essential in various
immunological responses. Activation of the RE
cells by a variety of techniques enhances the
immune response to particular antigens, while a
depression of RE function results in a decreased
immune response (24, 25). Also, macrophages have
been suggested to act as initiators of the immune
response (26-28), and to be essential in thymocyte
mitogenesis (29, 30). Furthermore, the role of
macrophages in the selective killing of neoplastic
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cells both specifically and nonspecifically has been
demonstrated (31). Their ability to perform these
various roles is related to their functional state.
The intent of the present manuscript is to de-
scribe a series ofexperiments examiningthe role of
the macrophage in environmental chemical-induced
immune alterations. While it is recognized that
macrophages cooperate in an integrated manner
with lymphocytes in the elaboration of an immune
response, the present study is restricted to macro-
phages, whereaslymphocytefunctionwillbereviewed
elsewhere by Silkworth (32).
Materials and Methods
Animals
Male Balb/c mice (18-20 g) were used throughout
all studies except certain tumor studies where
appropriate syngeneic strains were used. All mice
were fed powdered Wayne lab diet.
Chemicals
Polychlorinated biphenyl [Aroclor 1242 (Monsan-
to)], hexachlorobenzene (Eastman), and dieldrin
(Shell) were administered in the diet. Test parame-
ters were evaluated following 3, 6, and 18 weeks
dietary exposure.
Cell Isolation
Elicited peritoneal macrophages (PM) were
obtained by saline lavage of the peritoneal cavity
four days after an intraperitoneal (IP) injection of 1
ml of 6% Na caseinate. Cells were washed two
times in sterile saline and then resuspended to a
concentration of 2.0 x 106 cells/ml in Hanks Bal-
anced Salt Solution (HBSS, Gibco) with 2% fetal
calf serum (FCS, Gibco). The total cell suspension
contained 80-85% macrophages (as determined by
eosin Y ingestion), and about 5% PMN's and
lymphocytes as determined by using Turk's stain.
The average total cell yield was approximately 1 x
107 cells/mouse.
Elicited polymorphonuclear leukocytes (PMN's)
were obtained inthe same manner asthe peritoneal
macrophages except they were harvested 24 hr
after IP injection ofthe Na caseinate. The average
cell yield was approximately 1.5 x 107 cells per
mouse, and approximately 85% were PMN's (as
determined by Turk's stain).
Alveolar macrophages were obtained by saline
lavage ofthe lungs in ether anesthetized mice via a
cannula inserted into the trachea. Cells from two
Environmental Health Perspectivesanimals were pooled and adjusted to 0.5 x 106
cells/ml and served as one data point in each assay.
All other cell suspensions required only one animal
per data point.
Splenic marcophages were isolated from a sus-
pension of spleen cells that had been obtained by
finely mincing spleens in HBSS. The cells were
then suspended in HBSS with 2% FCS and then
incubated in tissue culture dishes (10 x 15 mm) at
37°C in a 5% CO2 humidified atmosphere for 3 hr.
Adherentcellswerecollected, resuspendedinHBSS
with2% FCS, and adjusted toaconcentration of2.0
x 106 cells/ml.
All cell counts were made by using a hemocytom-
eter, and viability was assessed by trypan blue dye
exclusion.
Oxygen Consumption
Oxygen consumption was measured by using a
Gilson recording oxygraph equipped with a Clarke
02 electrode as previously described (33). A volume
of1.6 ml containing 2.0 x 106 cells/ml in HBSS with
10% FCS was added to the chamber at 37°C and
the resting 02 consumption was measured for 8
min. After this time, 100 ,ul of an opsonized
Fleishmann's household yeast (Saccharomyces
cerevisiae) cake suspension was added to yield a
yeast:cell ratio of 1: 25. The yeast suspension was
preparedbyaddingapproximnately 1 gofFleishmann's
cake yeast to 100 ml of sterile 0.9% saline. This
preparation was boiled for 15 min, cooled, and
boiled again for 15 min to kill the yeast. Yeast
viability was assessed bymethylene blue exclusion.
The yeast then were opsonized in FCS for 30 min at
37°C and added to the cell suspension to yield a
final serum concentration of 20%. Oxygen utiliza-
tion during the phagocytic event was measured for
an additional 8 min.
Using the standardizing buffer (02 Probe Solu-
tion, Yellow Springs Instrument Company), the
recording oxygraph was calibrated for 16 cm. The
constant used for 16 cm is 50.4 and the formula is
ylx (constant) = puM 02/hr/106 cells.
Phagocytosis and Killing Assay
The method ofSimpson et al. (34) was used and is
described briefly. Equal volumes of test cells,
opsonized live yeast in aratio of1: 10 with test cells
and methylene blue (8 x 10-4 M) were placed into
sterile polypropylene 12 mm x 75 mm test tubes
with caps and were incubated at 37°C in a 5% CO2
humidified atmosphere on an aliquot shaker for 30
min. The cell suspensions were then centrifuged
(478g at 4°C for 6 min), and the supernatant was
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discarded. The cell pellet was resuspended in 20-50
,ul ofsterile saline, and wet mounts were made and
examined under oil immersion. A minimum of 100
cells distributed over five fields were examined.
The number ofphagocytically active cells, the total
number ofingested yeast and the number of killed
ingested yeast were enumerated. Thus, three pa-
rameters were measured: (a) the phagocytic capacity,
(b) the phagocytic activity, and (c) the microbicidal
activity:
Phagocytic capacity =
number of live and dead yeast ingested
100 cells
Phagocytic activity =
number of cells containing > 2 yeast
100 cells
Microbicidal activity =
number of dead ingested yeast
phagocytic capacity
Fibronectin Assay
Electroimmunoassay or "rocket" immunoelectro-
phoresis was used to quantitate plasma fibronectin
or opsonic protein levels as previously described
(35, 36). Experimental serum was assayed for
immunoreactivefibronectin. Blood samples obtained
from the abdominal vena cava were allowed to clot
for 60 min at 25°C prior to centrifugation to obtain
serum. It is recognized that the serum concentra-
tion ofcirculatingfibronectin (opsonic glycoprotein)
is consistently less than that of plasma due to the
incorporationorcovalentbindingofplasmafibronectin
to fibrin in the presence of Factor XIII (37). This
difference is minimal if the blood is allowed to clot
at room temperature prior to collection of serum
(38). All samples for analysis were carefully han-
dled under such constant conditions so that serum
could be the test media used for the immunoassay
as previously standardized (35). The serum was
diluted to 10%, and 10 RIwas added to each well cut
into the solidifed agarose-antiserum solution layer
on the glass plate (5 x 10 in.) used in the
electroimmunoassay. The samples were then moved
electrophoretically toward the anode at a voltage of
7.5 V/cm at 4°C for 22 hr by using an LKB
multiphore system. The plates were washed over-
night, pressed and dried, and subsequently stained
(35). Rocket heights were used as a quantitative
index ofimmunoreactive opsonic a2SB glycoprotein
81concentration. Rocket heights were recorded in
millimeters and a double reciprocal standard plot
(1/mm vs. 1/,ug opsonic or 1/mm vs. 1/% serum) was
defined with a DEC-10 computer for protein stan-
dards at varying concentrations. This standard
curve was used to determine serumimmunoreactive
opsonic a2SB glycoprotein in ,ug/ml (36).
Tumor Susceptibility Study
Syngeneicmiceweremaintained ondietscontaining
5 or 100 ppm ofPCB 1242 or HCB or 1 or 5 ppm of
dieldrin and then challenged at 3, 6, or 18 weeks
with appropriate syngeneic ascites-form tumorcells.
DBA/2 male mice (18-20 g) were challenged with
the methylcholanthrene-induced lymphomas, P388
or L1210. Male Balb/c mice (18-20 g) were chal-
lenged with the SV-40 virus-induced Balb/c kidney
tumor, mKSA. Male C57B1/6 mice (18-20 g) were
challenged with the benzo(a)pyrene-induced lym-
phoma EL-4. Tumor lines were maintained in
ascites form by weekly intraperitoneal (IP) inocula-
tion and serial passage. Tumor cells were obtained
for passage by peritoneal lavage with a 22 gauge
needle and 5 ml of sterile HBSS. Tumor cells were
washed three times in cold, sterile HBSS, counted,
and suspended to the appropriate concentration in
sterile HBSS for IP inoculation of 0.5 ml of the
suspension into isogeneic mice. The following doses
of live tumor cells were used: P388, 0.5 x 106;
EL-4, 2 x 105; mKSA, 1 x 107; and L1210, 0.5 x
105. The Litchfield test (39) was used foran analysis
oftime versus effect, and linearregression analysis
was used to compute the mean survival time.
Cytotoxicity Assay
Tumor cell (mKSA) killing was assessed in vitro
by 51Cr-release from labelled tumor target cells as
described by Canty and Wunderlich (40). The
effector: target cell ratio was 40:1. The cells were
suspended in RPMI 1640 (without phenol red)
supplemented with 20% FCS and incubated at 37°C
for 24 hr in a humidified atmosphere of 95% air:5%
CO2. Cytotoxicity was calculated by the method of
Nathan et al. (41) as follows:
Treated 51Cr release - Control 51Cr release
Maximum 51Cr release - Control 51Cr release
= % Cytotoxicity
Maximum release ofthe 51Cr label was determined
fromthe supernatant ofthrice freeze-thawed tumor
cells. Statistical differences were assessed by the
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Student t-test, and p < 0.05 was considered
significant.
The mKSA tumor target cells were harvested 10
days following their IP inoculation. Spleen cells
were obtained from nontumor-bearing mice which
had been receiving a dietary administration oftest
chemicals for 3, 6, or 18 weeks. Spleens were
removed asceptically and then teased through a
1OXX silk cloth. Adherent cells were obtained by
incubating approximately 1 x 107 spleen cells in 90
mm culture plates, previously coated with poly-L-
lysine, with RPMI 1640 supplemented with 10%
FCS at 37°C for 3 hr in a 95% air: 5% CO2
humidified atmosphere. Nonadherent cells were
decanted off, and adherent cells were removed by
gentle rubbing with a rubber policeman. All cell
preparations were washed three times in HBSS
before use.
Intravascular Clearance and Antigen
Processing
Phagocytic Determinations. The in vivo
phagocytic response of dieldrin treated mice to a
particulate antigen was measured by the vascular
clearance of 51Cr-labeled SRBC. Following admin-
istration of the chemical for two weeks, all groups
of mice, treated and controls, received an IV
administration of 0.1 cc of20% SRBC labeled with
7.2 ,uCi of Na25 CrO4. The 51Cr-SRBC were pre-
pared by the technique of Gray and Sterling (42).
After IV injection of the 51Cr-SRBC suspension,
0.01 cc aliquots ofheparinized blood were collected
fromthe tail veins at 1, 3, 5, 7, and 9min. The blood
radioactivity, as percentage of the injected dose,
was plotted semilogarithmically against time in
minutes and the intravascular half-time was calcu-
lated. Tissue distribution ofthe51Cr-SRBC suspen-
sionwas measured at 11 min. afterits injection, and
the radioactivity ofliver, lungs, and spleen expressed
as apercentage ofthe injected dose on aweight and
total organ basis.
AntigenProcessing. Male Balb/cmice (18-20g)
received a dietary administration of 0.5, 5.0, and
50.0 ppm of dieldrin for two weeks. Following the
two-week exposure period, macrophages were
harvested and allowed to phagocytize, in vitro,
opsonized sheep erythrocytes. Peritoneal macro-
phages were obtained by peritoneal lavage four
days following an IP injection of 1 cc of-6% Na
caseinate. Splenic macrophages were obtained by
surface adsorption to poly-L-lysine-coated tissue
culture plates. Alveolarmacrophages were obtained
by isotonic saline lavage of the lungs. Hepatic
Kupffer cells were obtained by enzymatic digestion
of the liver following an in situ perfusion (43).
Environmental Health PerspectivesSheep erythrocytes were opsonized in 40% FCS for
3 hr at 37°C on an aliquot mixer. The opsonized
51Cr-SRBC (44) were seeded onto macrophage
monolayers at an SRBC: macrophage ratio of 100:1
and phagocytosis was allowed to occur for 4 hr.
After this time, the plates were gently rinsed with
HBSSandthemacrophageswithingested51Cr-SRBC
were removed by a rubber policeman. An aliquot of
1 x 107 macrophages, from dieldrin or control mice
and containing, on the basis of radioactivity and
light microscopic examination, essentially equal
numbers of SRBC was injected into control Balb/c
mice. Splenic plaque forming cells were enumer-
ated by theJerne and Nordin (45) technique on the
peak response day. Preliminary studies revealed
day 4 to be peak response day.
Statistical Analysis
All data, where appropriate, were analyzed by
using the Student t-test. A probability level p <
0.05 was considered to be statistically significant.
All data are presented as the mean ± SEM.
Results
Oxygen Consumption, Phagocytic and
Microbiocidal Activity
The present studies indicate that PCB 1242 or
HCB administered in the diet at 167 ppm for3, 6, or
18 weeks did not significantly alter, in any consis-
tent manner, oxygen utilization, phagocytic activ-
ity or microbicidal activity in phagocytic cells
(Table 1). However, certain individual parameters
were altered but not in any temporal pattern. The
resting 02consumption ofPMNs from HCB treated
mice was significantly lower than controls at 3
weeks but this change was not reflected in any
functional alterations. In general, the resting rate
Of 02 consumption as well as the respiratory burst
increased with age in all groups, treated as well as
controls, which possibly represents a maturational
development.
The phagocytic activity, phagocytic capacity and
microbicidal activity ofalveolar, splenic and perito-
neal macrophages and PMNs was not altered, in
any consistent manner, by PCB 1242 or HCB
following dietary administration lasting up to 18
weeks. Furthermore, the isolated incidences where
alterations did occur were not related to any
previously determined (12, 13) in vivo host defense
and/or immunological measurements (Table 2).
Amodulator ofcell surface activity, i.e, fibronectin,
a surface binding glycoprotein, was measured and
was found to be significantly decreased, primarily
at the 18 week test period (Table 3). In general, an
approximate 40% reduction, below control values,
was observed in the fibronectin levels in the chemi-
cal treated mice following 18 weeks of dietary
administration of the chemicals. Coincident with
the decrease in serum fibronectin was a significant
increase in the susceptibility of the chemical-
treated mice to a challenge of ascites tumor cells
(Tables 4-7). This increased susceptibility was most
marked at the 18 week test period.
Tumor susceptibility of PCB 1242, HCB, and
dieldrin treated syngeneic mice was assessed using
ascites form of tumor cell implants from chemical
and/or virus transformed cell lines bearing diverse
H-2and Mls antigens. The DBA/2 tumors (P388 and
Table 1. Influence of PCB 1242 and HCB on oxygen utilization by macrophages and neutrophils.a
Oxygen utilization, p.M 02/hr/106 cells
Alveolar macrophages Splenic macrophages Peritoneal macrophages PMN's
Time, weeks Resting % Burst Resting % Burst Resting % Burst Resting % Burst
Control 3 20.3 t 2.7 15.1 ± 8.6 3.3 ± 0.5 16.3 ± 7.6 5.9 ± 0.4 48.1 ± 10.9 5.0 ± 0.4 160.4 ± 28.6
6 23.4 ± 3.4 13.9 ± 14.5 3.4 ± 0.7 10.9 ± 4.2 7.2 ± 1.0 53.4 ± 11.8 8.2 ± 0.4 144.2 ± 29.4
18 44.9 ± 5.5 27.3 ± 6.6 9.5 ± 2.8 24.4 ± 4.1 10.7 ± 1.0 42.7 ± 8.4 10.9 ± 0.7 133.8 ± 24.2
PCB 1242 3 18.1 ± 2.6 17.8 ± 9.3 2.9 ± 0.5 28.3 ± 6.1 6.3 ± 0.5 36.1 ± 4.8 6.6 ± 1.1 142.0 ± 30.0
6 18.4 ± 2.1 37.7 ± 11.4 2.9 ± 0.3 30.6 ± 14.6 8.5 + 0.7 36.2 ± 8.0 8.3 ± 0.5 110.9 ± 81.1
18 48.1 ± 6.5 16.8 ± 5.0 9.2 ± 1.9 25.7 ± 8.4 10.5 ± 0.6 50.2 ± 14.3 10.7 ± 0.7 162.2 ± 33.6
HCB 3 23.2 ± 4.2 15.8 ± 3.1 3.2 ± 0.5 14.9 ± 5.8 6.3 ± 0.4 25.8 ± 8.6 6.3 ± 0.3* 96.6 ± 25.9
6 18.1 ± 2.4 39.4 ± 15.9 2.9 ± 0.4 20.0 ± 4.0 7.7 ± 1.2 30.1 ± 9.3 6.9 ± 0.6 97.8 ± 18.2
18 43.1 ± 6.6 28.2 ± 6.5 12.3 ± 2.2 24.8 ± 3.6 11.1 ± 0.7 31.2 ± 5.5 9.6 ± 0.5 106.6 ± 14.2
aPCB 1242 and HCB were administered in the diet for 3, 6, or 18 weeks at 167 ppm. Controls received Wayne lab diet without
chemicals. The cells wereprepared asdescribed in Materials and Methods. All data are presented as the mean + SEM and significance
at p < 0.05 indicated by an asterisk. All data points consist of ¢ 9 individual studies.
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Environmental Health Perspectives 84Table 3. Serum fibronectin concentrations in mice fed PCB
1242, HCB, or dieldrin.a
Fibronectin concentration, % of control
Treatment 3 weeks 6 weeks 18 weeks
PCB
5 ppm 139 83 40*
100 ppm 99 78* 45*
HCB
5 ppm 115 72 74
100 ppm 92 70* 52*
Dieldrin
1 ppmb 42* 131 86
5 ppm 107 100 51*
aPresented as % ofcontrol mean with an asterisk (*) denoting
siXgiificance at p < 0.05; n = 7-10 for each group.
bDieldrin (1 ppm) study was conducted independently and
significance is based on its own control group.
Table 4. Mean survival time in mice fed PCB 1242, HCB, or
dieldrin and challenged with mKSA tumor cells.a
Mean survival time, days
Treatment 3 weeks 6 weeks 18 weeks
Control 19.8 20.0 21.3
PCB
5 ppm 19.2 19.2 20.0
100 ppm 17.6 18.1 18.0
HCB
5 ppm 19.8 18.8 18.5
100 ppm 20.6 14.0* 11.4*
Dieldrin
1 ppmb 24.0 19.4 14.3*
5 ppm 17.4 18.2 14.2*
aAscites tumor cells mKSA-Tu5 (1.0 x 107/ml) were injected
intraperitoneally (IP) in 0.5 ml sterile isotonic saline following a
3, 6, or 16 week dietary administration of PCB 1242, HCB or
dieldrin. The percent cumulative mortality was recorded and the
mean survival time was determined. The asterisk (*) denotes
sigificance at p < 0.05; n = 7-10 for each group.
Dieldrin (1 ppm) study was conducted independently and
significance is based on its own control group.
L 1210) both have H-2d and Mls1 antigens whereas
the Balb/c tumor mKSA has an H-2d and Mls2
antigen and the C57B1/6 tumor line EL-4 has an
H-2b and MIs2 antigen. The Mls locus resides
outside the H-2 complex and is an important
stimulus in themixed lymphocyte response (MLR).
As can be seen in Tables 4-7, PCB 1242 at dose
levels of5 or 100 ppm did not alter tumor suscepti-
bility for periods up to 1$ weeks dietary exposure.
This lack of susceptibility to tumor challenge was
observed in all four tumor models. However, a
marked increase in susceptibility to tumor chal-
lenge was observed in mice administered HCB or
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Table 5. Mean survival time in mice fed PCB 1242, HCB, or
dieldrin and challenged with EL-4 tumor cells.a
Mean survival time, days
Treatment 3 weeks 6 weeks 18 weeks
Control 28.6 30.1 31.1
PCB
5 ppm 26.7 27.9 31.0
100 ppm 18.8* 29.8 32.3
HCB
5 ppm 27.0 27.3 28.1
100 ppm 22.4* 19.2* 13.9*
Dieldrin
1 ppmb 21.6* 23.4* 22.1*
5 ppm 20.7* 17.7* 9.0*
aAscites tumor cells EL-4 (2 x 105) were injected IP in 0.5 ml
sterile isotonic saline following a 3, 6, or 18 week dietary
administration ofthe chemicals. The percent cumulative mortal-
ity was recorded and the mean survival time was determined.
Theasterisk(*)denotessignificanceatp < 0.05; n = 7-10foreach
group.
bDieldrin (1 ppm) study was conducted independently and had
its own control group.
Table 6. Mean survival time in mice fed PCB 1242, HCB, or
dieldrin and challenged with P388 tumor cells.a
Mean survival time, days
Treatment 3 weeks 6 weeks 18 weeks
Control 24.3 25.9 25.5
PCB
5 ppm 23.9 24.8 27.0
100 ppm 22.7 25.3 27.1
HCB
5 ppm 21.0 20.1* 19.3*
100 ppm 20.2* 16.5* 11.7*
Dieldrin
1 ppmb 24.0 22.2* 19.1*
5 ppm 19.0 15.0* 9.1*
aAscites tumorcellsP388(0.5 x 106)were injected IPin0.5 ml
sterile isotonic saline following a 3, 6, or 18 week dietary
administration of the test chemicals. The percent cumulative
mortality was recorded and the mean survival time was deter-
mined. The asterisk (*) denotes significance atp < 0.05; n = 7-10
for each group.
bDieldrin (1 ppm) study was conducted independently and had
its own control group.
dieldrin in their diets and challenged with either of
the fourtumorcell lines. This increased susceptibil-
ity was demonstrated to be related to the length of
dietary exposure to HCB and dieldrin and to the
dosage of the chemical. The H-2 complex or Mls
locus did not appear to be an important factor in
that differential susceptibility to either of the
tumor cell lines was not evident.
To ascertain a possible cellular lesion responsible
85Table 7. Mean survival time in mice fed PCB 1242, HCB, or
dieldrin and challenged with L 1210 tumor cells.a
Mean survival time, days
Treatment 3 weeks 6 weeks 18 weeks
Control 18.1 17.5 18.4
PCB
5 ppm 18.0 18.4 19.2
100 ppm 17.5 18.1 19.7
HCB
5 ppm 17.0 14.1* 11.2*
100 ppm 10.5* 7.2* 6.4*
Dieldrin
1 ppmb 17.7 16.0 14.0*
5 ppm 12.1* 10.2* 5.1*
aAscites tumor cells L 1210 (0.5 x 105) were injected IP in 0.5
ml sterile isotonic saline following a 3, 6, or 18 week dietary
administration of the test chemicals. The percent cumulative
mortality was recorded and the mean survival time was deter-
mined. Theasterisk (*) denotes significance atp < 0.05; n = 7-10
for each group.
bDieldrin (1 ppm) study was conducted independently and had
its own control group.
Table 8. Influence ofPCB 1242, HCB, and dieldrin on splenic
cytocidal activity against mKSA tumor cells.a
Cytotoxicity, % of control
PCB HCB Dieldrin
Time,
weeks 5 ppm 100 ppm 5 ppm 100 ppm 1 ppm 5 ppm
3 98 100 95 82* 92 77*
6 100 95 87* 71* 91 48*
18 92 98 80* 52* 84* 34*
aThe cytotoxic activity of a total spleen cell preparation
against 51Cr-mKSA tumor cells was assessed using isolated
spleen cells from nontumor-bearing PCB; HCB; or dieldrin-
treated mice. Data are presented as percent of control with an
asterisk (*) denotingsignificance atp < 0.05; n = 7-10pergroup.
PCB and HCB were administered in the diet at 5 and 100 ppm
and dieldrin was administered at 1 and 5 ppm.
for the enhanced susceptibility of HCB and dieldrin-
treated mice to the tumor cell challenges, splenic
macrophage and lymphocyte tumoricidal activity
wasevaluated. InTable8thetotalsplenictumoricidal
activity of a heterogenous population ofspleen was
assessed against mKSA tumor cells. PCB 1242 at 5
or 100 ppm did not alter splenic tumoricidal activi-
ty. However, HCB and dieldrin at their respective
maximal doses, 100 and 5 ppm, respectively,
significantly impaired tumor cell killing as early as
three weeks after dietary exposure. At 5 ppm,
HCB impaired tumorcellkillingby 6weekswhereas
at 1 ppm dieldrin did not alter tumor cell killing
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Table 9. Influence ofPCB 1242, HCB, and dieldrin on splenic
nonadherent cell killing of mKSA tumor cells.a
PCB
Cytotoxicity, % of control
HCB Dieldrin
Time,
weeks 5 ppm 100 ppm 5 ppm 100 ppm 1 ppm 5 ppm
3 120* 105 87 83* 77* 54*
6 118 100 89 81* 70* 30*
18 100 101 90 84* 73* 23*
aThe cytotoxic activity of nonadherent spleen cell against
"Cr-mKSA tumor cells was assessed using spleen cells from
non-tumorbearing mice administered PCB; HCB; ordieldrin for
3, 6, or 18 weeks. All data are presented as percent of control
withanasterisk(*) denotingsignificance atp < 0.05;n = 7-10per
group. PCB and HCB were administered in the diet at 5 and 100
ppm and dieldrin was administered at 1 and 5 ppm.
activity of spleen cells until 18 weeks after dietary
exposure.
Further studies to delineate the cell type in-
volved were conducted using nonadherent and
adherent spleen cells. PCB 1242 (5 ppm) had a mild
stimulatory effect on nonadherent (lymphocyte)
spleen cell tumor cell killing (Table 9). The high
dose of PCB 1242 (100 ppm) was ineffective in
altering splenic nonadherent cell tumor cell killing.
HCB at a concentration of 100 ppm induced an
approximate 20% reduction in tumor cell killing.
This reduction was constant from 3 to 18 weeks of
the dietary administration of HCB. At 1 ppm
dieldrin induced an approximate 30% reduction in
splenic nonadherent cell tumoricidal activity which
was held constant for up to 18 weeks. However, at
5 ppm dietary administration ofdieldrin, an approx-
imate 50% reduction in splenic nonadherent cell
tumor cell killing ability was manifested. This
reduction was exacerbated with increased time of
dietary exposure in that by 18 weeks, the 5 ppm
dieldrin-treated animals had only 23% of control
value tumoricidal activity (Table 9).
Adherent cell (macrophage ?) tumoricidal activ-
ity was not altered by either the low dose of PCB
1242 (5 ppm) or dieldrin (1 ppm) administered for3,
6, or 18 weeks (Table 10). However, at the high
dose of PCB and dieldrin, 100 ppm and 5 ppm,
respectively, a significant decrease in tumor cell
killing was observed at each integral tested. Ad-
herent cells from the high dose PCB and dieldrin
manifested a tumoricidal activity which was
approximately 80% of control values (Table 10).
This reduction was not exacerbated with time on
diet. In contrast, HCB at a dietary administration
of5 and 100 ppm produced a time- and dose-related
decrease in adherent cell tumoricidal activity. By
Environmental Health PerspectivesTable 10. Influence of PCB 1242, HCB, and dieldrin on
splenic adherent cell killing of mKSA tumor cells.a
Cytotoxicity, % of control
PCB HCB Dieldrin
Time,
weeks 5 ppm 100 ppm 5 ppm 100 ppm 1 ppm 5 ppm
3 97 82* 75* 50* 94 83*
6 97 80* 60* 27* 96 80*
18 94 76* 52* 11* 93 80*
aThecytotoxicactivityofadherentspleencellagainst5lCr-mKSA
tumor cells was assessed using spleen cells from non-tumor
bearing mice administered PCB; HCB; or dieldrin for 3, 6, or 18
weeks. All data are presented as percent of control with an
asterisk (*)denotingsignificance atp < 0.05; n = 7-10pergroup.
PCB and HCB were administered in the diet at 5 and 100 ppm
and dieldrin was administered at 1 and 5 ppm.
18 weeks after dietary administration of 5 ppm of
HCB, adherent cells had only 52% of control cell
tumor cell killing activity and 100 ppm only 11%
(Table 10).
Anevaluation oftheinvivo phagocytic activityof
fixed tissue macrophages ofthe RES revealed that
a dose-related decrease in the vascular clearance of
51Cr-SRBC was associated with an impaired he-
patic and splenic, but not alveloar, clearance ofthe
lCr-SRBC in dieldrin-treated mice (Table 11).
Although on a per total organ basis the hepatic
localization of the 51Cr-SRBC was greater in the
dieldrin-treated mice, the content ofthe51Cr-SRBC
expressed on a per gram basis was decreased. This
may be a reflection of dieldrin-induced hepatic
parenchymal cell hypertrophy and/or hyperplasia
and a decrease in number and/or function ofhepatic
Kupffer cells.
To further ascertain the functionality of macro-
phages in dieldrin-treated mice, peritoneal, splenic,
hepatic, and alveolar macrophages were isolated
from mice which received a dietary administration
of0.5, 5.0, or 50.0 ppm ofdieldrin for 2 weeks and
evaluated for their ability to present an adequate
immunogen to control mice (Table 12). Immunogen
transfer was assessed by splenic plaque forming
cell development in recipient mice. As can be seen
in Table 12, all four populations of macrophages
obtained from high dose (50 ppm) treated mice had
animpairedabilitytopresent anadequate imununogen
to control mice. A dose-related decrease was most
evident in splenic and peritoneal macrophages.
However, splenic andalveolarmacrophages appeared
to be the most sensitive, with regard to dosage, in
that both populations manifested a significant re-
duction in antigen processing when exposed to only
0.5 ppm of dieldrin.
Discussion
Macrophages have been recognized for many
years to play a crucial role in resistance to intracel-
lular infection, to act as accessory cells in the
immune response, and to function as cytotoxic cells
acting against tumor cells or virally infected cells.
Their ability to perform these various roles is
related to their functional state (46).
Although previous studies which have demon-
strated an impaired antibody formation and
heightened sensitivity to endotoxin and malaria in
xenobiotic-treated mice suggested a macrophage
defect, specific functional assessments were not
conducted. As our knowledge of cellular coopera-
tion in the generation of an immune response
expands, the designation, at the present time, of a
Table 11. Vascular clearance and tissue distribution of 51Cr-SRBC in dieldrin-treated mice.a
Tissue distributionb
Liver Lung Spleen
Dieldrin, ppm t4,2, minc % ID/g % ID/TO % ID/g % ID/TO % ID/g % ID/TO
0 5.7 ± 0.2 23.9 ± 1.2 67.3 ± 3.3 5.4 ± 0.8 0.93 ± 0.1 16.6 ± 1.0 2.2 ± 0.2
0.5 7.1 ± 0.5 20.0 ± 1.8 69.9 ± 5.4 4.0 ± 0.5 0.88 ± 0.1 15.2 ± 1.1 2.0 ± 0.1
5.0 11.9 ± 1.1* 12.2 ± 1.1* 77.6 ± 4.8 5.3 ± 0.8 0.92 ± 0.6 9.1 ± 0.9* 1.6 ± 0.8
50.0 20.2 ± 2.3* 5.4 ± 2.9* 84.4 ± 7.1* 5.9 ± 0.6 0.80 ± 0.9 6.0 ± 1.8* 1.0 ± 0.1*
aMice were maintained on diet for 2 weeks afterwhich all mice received 0.1 cc of20% SRBC labeled withNa51Cro4 containing 7.05
M.ci.
bTissue distribution ofthe 5"Cr-SRBC was measured 11 min after injection, and tissue radioactivity is expressed as percentage of
theinjected dose(%ID) on aweightandtotalorganbasis. Dataexpressed as mean ± SEM, where anasterisk(*) denotessignificance at
p < 0.05; n = 10 throughout.
cVascular clearance was determined by taking 0.1 cc aliquots of blood from the tail vein at 1, 3, 5, 7, and 9 min. The blood
radioactivity, as percentage of the injected dose, was plotted semilogarithmically against time in minutes, and the intravascular
half-time tl12 calculated.
June 1981 87Table 12. Comparative influence oftransferred antigen-exposed macrophages from normal and dieldrin-treated Mice on splenic
plaque formation in control naive mice.a
PFC/spleenb
Dieldrin, ppm Peritoneal macrophages Splenic macrophages Alveolar macrophages Kupffer cells
0 34,651 + 1,477 43,869 + 3,871 22,207 + 1,970 17,041 + 976
0.5 29,020 - 1,641 33,298 ± 2,710* 15,001 + 1,432* 14,277 + 1,122
5.0 15,775 + 2,013* 12,656 + 1,174* 13,795 ± 987* 13,998 ± 1,002
50.0 7,897 + 696* 9,023 ± 862* 10,625 + 1,125* 9,844 + 1,217*
aBalb/c male mice were maintained on dieldrin-containing diets for 2 weeks.
bPeritoneal and alveolar macrophages were harvested by saline lavage. Hepatic Kupffer cells were isolated by an enzymatic
procedure (42) and splenic macrophages were isolated by surface adsorption. SRBC were opsonized in 40% FCS for30minand labeled
with Na51CrO4. Macrophage cultures were seeded with the opsonized 51Cr-SRBC at a SRBC: macrophage ratio of 100:1 and
co-incubated for 3 hr. An inoculum ofmacrophages-( 1 x 107) containing auniform radioactivity (control = experimental) was injected
into control Balb/c mice. Peak splenic PFC formation (day 4) was determined. Data are presented as the mean ± SEM, where an
asterisk (*) denotes significance at p < 0.05; n = 10 throughout.
specific cellular lesion being responsible for
xenobiotic-induced immune dysfunction may be
naive. Nonetheless, for experimental purposes the
immune system does lend itself to dissection of its
cellular components and in this way discrete cellu-
lar functions may be ascertained.
An attempt has been made to conceptualize the
possible modes ofaction ofenvironmental chemical
contaminants relative to their influence on immune
parameters. As can be seen in Figure 1, we feel the
chemicals may act either directly or indirectly on
immunocompetent cells inducing a stimulation or
suppression, which may be time- and dose-related.
The direct influence may be via plasma membrane
alterations, molecular interference, or by cytotoxic
actions. Indirect actions via metabolic perturba-
tions mediated by altered nutritional and/or endo-
crine parameters must also be considered.
In the present study, an assessment of in vivo
and in vitro macrophage function was conducted.
The overall design was directed toward evaluating
what we felt would be a measure of affector and
effector macrophage function using in vitro and in
vivo studies.
TTiABO LIC ALTERATION
IINIUICO SU PPRESSANT / STINlCUT
IDIRECT CYTOTOXICrTS'
i
ENVIRONNICN'TAL CHEMICAL
HAPTEN
ANTIGEN
TOLEROGEN
MOLECULAR INrEHEERENCE
FIGURE 1. Possible roles of environmental chemicals in induc-
tion of immune alterations.
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Oxygen consumption as a concomitant of the
phagocytic event has been utilized as an index of
the metabolic status of the macrophage. The
respiratory burst which occurs duringphagocytosis
is energy dependent (47). The demonstration that
isolated macrophages from chemical-treated mice
have no alteration in either their resting 02 con-
sumption or in the 02 consumption duringphagocy-
tosis suggests that the phagocytic event is not
impaired (Table 1). In support ofthis observation is
the demonstration that these cells have no alter-
ation in their phagocytic activity or phagocytic
capacity (Table 2). However, the invitro phagocytic
and 02 utilization studies used particles opsonized
with fetal calf serum which would not allow a
detection of a serum defect. In this regard, the
serum concentration of fibronectin, an a2 opsonic
surface-binding glycoprotein, was shown to be
decreased (Table 3). Therefore, the decreased vas-
cular clearance ofthe 51Cr-labeled SRBC (Table 9)
and its altered tissue distribution may be due to a
serum opsonin (fibronectin) deficit rather than a
phagocytic defect in the macrophage. The utiliza-
tion of control serum and treated cells and vice
versa (treated serum and treated cells) allows a
discrimination between a cellular defect versus a
humoral defect in an evaluation of macrophage
phagocytosis.
The phagocytic clearance capability of macro-
phages that comprise the majority of the reticulo-
endothelial system (i.e., hepatic Kupffer cells and
splenicmacrophages) has classicallybeenmeasured
by the vascular clearance ofgelatinized colloid. The
clearance capacity of this system of sessile phago-
cytes toward gelatin-stabilized colloid has been
showntonotonly depend upondelivery ofcolloid to
the RES or the innate phagocytic capability of the
cells but also upon a specific plasma protein for-
Environmental Health Perspectivesmerly designated aspecific opsonin, humoral recog-
nition factor or opsonic x2 surface binding (SB)
glycoprotein (35, 36). Recently this protein has
been shown to be identical to a plasma protein
originally called cold-insoluble globulin, but now
more commonly called plasma fibronectin (36).
Studies investigating the participation of the
RES in host defense have demonstrated that RES
depression following traumatic injury, sepsis, or
during tumor growth (48) is associated with de-
creased amounts of circulating opsonic fibronectin
or a depression in the ability of fibronectin in the
plasma to mediate in vitro macrophage uptake of
test colloids. Thus, the presence ofadequate levels
ofcirculating opsonic fibronectin is important in the
maintenance of host defense mechanisms that are
dependent upon RES macrophage function. The
site of synthesis of this important plasma protein
has yet to be determined. However, tissue culture
studies have revealed that a variety ofcell types of
mesenchymal origin synthesize a glycoprotein
associated with the cell surface which mediates cell
attachment to substratum. This glycoprotein is
antigenically related to plasma fibronectin and is
significantly decreased on the fibroblast surface
following oncogenic transformation ofthe cells (49).
Thus, lossofgrowthcontrolobservedintransformed
celllines mayinpartbe dependentupon aninability
to synthesize adhesive fibronectin. Although the
cell associated form offibronectin and that found in
the circulation are antigenically related, the two
forms ofthe molecule are not identical. The plasma
form and cellularform differwith respect to certain
structural and functional properties (49). The ma-
jority ofthe cell surface forn exists in apolymerized
form while that in the plasma is mainly dimeric in
nature consisting of two disulfide crosslinked mo-
nomers, each with a molecular weight of 220,000.
The protein found in fibroblast-conditioned medi-
um, although consisting ofa high proportion ofthe
dimeric form, is much more active than the plasma
form in the agglutination of fixed sheep red blood
cells. Other studies have demonstrated slight dif-
ferences in molecular weight between cell and
plasma form which may suggest that the cell
surface form is a precursor to the plasmaform (50).
Studies from this laboratory have demonstrated
that the toxicological agents polychlorinated biphe-
nyl (PCB) and hexachlorobenzene (HCB), which
are common environmental chemical contaminants,
result in the depression ofplasma fibronectin levels
in mice that was temporally associated with an
increase in the sensitivity ofthe mice to the mKSA
ascites tumor (51). This was not due to a general
decrease in plasma protein synthesis or to
hemodilution, since there were no alterations in
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other plasma protein levels. In association with
these in vivo alterations in host defense there was
an inverse relationship between plasma fibronectin
levels and spontaneous macrophage spreading as
measured invitro. It cantherefore be hypothesized
that certain environmental toxicological agents may
depress synthesis orenhancedegradation ofplasma
opsonic fibronectin thus compromising RES host
defense mechanisms by severely limiting macro-
phage phagocytic clearance function.
In the present study, in vivo host defense was
evaluated by assessing the response ofthe treated
mice to an injection of a tumor implant. The
hypothesis that macrophages play a vital function
in tumor rejection is now supported by many
investigators. This was initially based upon the
evidence oftissue histiocytes in animal tumors and
the tumoricidal activity of activated macrophages.
Furthermore, stimulation of the RES with im-
munological adjuvants or with a variety of chronic
infections has been shownto enhance the resistance
of animals to unrelated infections as well as to
tumors (52). This resistance has been shown to be
mediated by activated macrophages. Macrophage
tumoricidal activity does not require phagocytosis
of the tumor cell but does parallel the level of
protein synthesis (53, 54) and has been correlated
with enhanced microbicidal activity in activated
macrophages (55, 56). The significantly impaired
resistance to challenge with various types oftumor
cell lines (Tables 4-7) which was demonstrated in
HCB and dieldrin exposed mice may be a reflection
of an altered tumoricidal activity of macrophages
and/or lymphocytes from the xenobiotic-treated
mice.
To assess this possibility, spleen cell tumoricidal
activity was evaluated using a total spleen cell
preparation from PCB, HCB and dieldrin treated
mice as well as a spleen cell preparation that
contained mainlyeitheradherentcells (macrophages
?) or nonadherent cells (lymphocytes ?). The
unfractionated spleen cell population as used in the
present study has similarly been used to detect
naturalkiller (NK) cells which have been suggested
to play a role in resistance to some tumors in vivo
(57). NK cells have been demonstrated to be
distinct from activated macrophages in physical
characteristics, target selectivity, genotype distri-
bution and the mechanism ofcytolysis (57). Howev-
er, since in vivo treatment with antimacrophage
agents, such as silica and carrageenan, depress NK
activity in vitro and since macrophages and NK
cells are relatively radioresistant, an interaction
between NK and macrophages in their tumoricidal
activity may be occurring in vivo (57). The absence
of any alteration in the unfractionated spleen cell
89tumoricidal activity in PCB-treated mice may indi-
cate the absence of any alteration in NK cell
activity. However, such was not the case in HCB
and dieldrin-exposed mice in that both groups,
dieldrin more so than HCB, had a significant
depression in tumor cell killing ability. However,
when the spleen cells were fractionated into adher-
ent and nonadherent populations it appeared that
the adherent cell population was the cell type
influenced most by HCB, whereas the target cell
for dieldrin appeared to be the nonadherent spleen
cell. Of interest was the observation of a slight
stimulation ofnonadherent cell tumoricidal capabil-
ity in PCB-exposed mice and a depression in
adherent cell cytocidal capacity. Since NK cells as
well as activated macrophages may kill target cells
by an antibody-dependent as well as an antibody-
independent means (58, 59), the present results
may suggest that NK cells are the target cells
which are impaired in dieldrin-treated mice and
that macrophages, perhaps activated in vitro by
surface adsorption, are the target cells which are
impaired in HCB-treated mice and PCB-treated
mice. Since it is possible that NK activity is
modulated by macrophages, the use of the beige
mouse mutant which has impaired NK activity (60)
but not macrophage activity may be useful in
dissecting the influence of the xenobiotics on NK
versus macrophage tumor cell killing.
Since it has been demonstrated that macrophage
processing of antigen may be an important deter-
minant for tumor immunity (61), the present study
examined antigen processing ability of diverse
populations of macrophages from dieldrin-exposed
mice. In this study, it was discovered that macro-
phages from dieldrin-treated mice which were al-
lowed to ingest a standard antigen load manifested
a significant impairment in their ability to transfer
an adequate immunogen to naive control mice.
Although peritoneal and splenic macrophages dem-
onstrated the greatest degree of suppression
(approximately 5-fold) at the highest dose of diel-
drin (50 ppm), splenic and alveolar macrophages
were the most sensitive macrophage types in that
they manifested adecreased response at the lowest
dieldrin dose.
Perhaps diversion of lysosomal enzymes away
from antigen digestion and/or the induction of a
population of macrophages (suppressor ?, scaven-
ger ?) unable to induce an antibody-forming re-
sponse in recipient mice may account for the
depressed response in the animals which received
the transferred macro phages. These results, in
conjunction with the previously described studies,
may be interpreted to indicate either that the
effector but not affector function ofthe macrophage
is impaired by xenobiotics and/or that this may be
the result ofa selective induction ofa population of
macrophages, normally heterogeneous in function,
which are now homogenous in function.
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